Public attitudes towards genomic risk profiling as a component of routine population screening

Genome

Volumn 56, Issue 10, 2013, Pages 627-633

  Nicholls, S G ^a   Wilson, B J ^a   Craigie, S M ^a   Etchegary, H ^b   Castle, D ^c   Carroll, J C ^d,e   Potter, B K ^a   Lemyre, L ^a   Little, J ^a  

^a UNIVERSITY OF OTTAWA   (Canada)

^b MEMORIAL UNIVERSITY OF NEWFOUNDLAND   (Canada)

^c UNIVERSITY OF EDINBURGH   (United Kingdom)

^d MOUNT SINAI HOSPITAL   (Canada)

^e UNIVERSITY OF TORONTO   (Canada)

Author keywords

Evaluation; Personalized medicine; Public health; Screening; Utility

Indexed keywords

ADULT; AGED; ARTICLE; ATTITUDE TO HEALTH; COLORECTAL TUMOR; FEMALE; GENETIC PREDISPOSITION; GENETIC PRIVACY; GENETIC SCREENING; GENOMICS; HUMAN; HUMAN GENOME; INSULIN DEPENDENT DIABETES MELLITUS; MALE; MIDDLE AGED; NEWBORN; NEWBORN SCREENING; PENETRANCE; PERSONALIZED MEDICINE; PSYCHOLOGICAL ASPECT;

ADULT; AGED; ATTITUDE TO HEALTH; COLORECTAL NEOPLASMS; DIABETES MELLITUS, TYPE 1; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENETIC PRIVACY; GENETIC TESTING; GENOME, HUMAN; GENOMICS; HUMANS; INDIVIDUALIZED MEDICINE; INFANT, NEWBORN; MALE; MIDDLE AGED; NEONATAL SCREENING; PENETRANCE;

EID: 84889785034     PISSN: 08312796     EISSN: None     Source Type: Journal    
DOI: 10.1139/gen-2013-0070     Document Type: Article

References (71)

1. Aas K.K. Tambs K. Kise M.S. Magnus P. Rønningen K.S. 2010. Genetic testing of newborns for type 1 diabetes susceptibility: a prospective cohort study on effects on maternal mental health. BMC Med. Genet. 11: 112. 10.1186/1471-2350-11-112. 20630116.
2. American Cancer Society. 2012. Colorectal cancer. [Online.] Available from: http://www.cancer.org/cancer/colonandrectumcancer/detailedguide/index [accessed 15 April 2013].
3. Andrykowski M.A. Munn R.K. Studts J.L. 1996. Interest in learning of personal genetic risk for cancer: a general population survey. Prev. Med. 25: 527-536. 10.1006/pmed.1996.0086. 8888320. (Pubitemid 26315224)
4. Armstrong D. Gosling A. Weinman J. Marteau T.M. 1997. The place of inter-rater reliability in qualitative research: an empirical study. Sociology, 31 (3): 597-606. 10.1177/0038038597031003015.
5. Armstrong K. Putt M. Halbert C.H. Grande D. Schwartz J.S. Liao K. et al 2012. The influence of health care policies and health care system distrust on willingness to undergo genetic testing. Med. Care, 50: 381-387. 10.1097/MLR.0b013e31824d748b.
6. Atkinson M.A. Eisenbarth G.S. 2001. Type 1 diabetes: new perspectives on disease pathogenesis and treatment. Lancet, 358 (9277): 221-229. 10.1016/s0140-6736(01)05415-0. (Pubitemid 32718550)
7. Auffray C. Caulfield T. Khoury M.J. Lupski J.R. Schwab M. Veenstra T. 2011. Genome Medicine: past, present and future. Genome Med. 3 (6). 10.1186/gm220.
8. Ayatollahi H. Bath P.A. Goodacre S. 2009. Accessibility versus confidentiality of information in the emergency department. Emerg. Med. J. 26 (12): 857-860. 10.1136/emj.2008.070557. 19934127.
9. Bombard, Y., Abelson, J., Simeonov, D., and Gauvin, F.P. 2013. Citizens' perspectives on personalized medicine: a qualitative public deliberation study. Eur. J. Hum. Genet. [Advance online publication.] 10.1038/ejhg.2012.300.
10. Bowling, A. 2004. Research methods in health. Open University Press, Maidenhead, UK.
11. Boyatzis, R.E. 1998. Transforming qualitative information. Sage Publications, Thousand Oaks, USA.
12. Bryman, A. 2004. Social research methods. Oxford University Press, Oxford, UK.
13. Burton H. Sagoo G.S. Pharoah P. Zimmern R.L. 2012. Time to revisit Geoffrey Rose: strategies for prevention in the genomic era? Ital. J. Public Health, 9 (4): e8665-1-e-9. 10.2427/8665.
14. Burton H. Chowdhury S. Dent T. Hall A. Pashayan N. Pharoah P. 2013. Public health implications from COGS and potential for risk stratification and screening. Nat. Genet. 45 (4): 349-351. 10.1038/ng.2582. 23535723.
15. Canadian Cancer Society. 2011. Canadian Cancer Statistics 2011. Canadian Cancer Society, Toronto, Ont.
16. Carroll J.C. Rideout A.L. Wilson B.J. Allanson J. Blaine S.M. Esplen M.J. et al 2009. Genetic education for primary care providers. Improving attitudes, knowledge, and confidence. Can. Fam. Physician, 55: e92-e99. 20008584.
17. Carroll J.C. Wilson B.J. Allanson J. Grimshaw J. Blaine S.M. Meschino W.S. et al 2011. GenetiKit: a randomized controlled trial to enhance delivery of genetics services by family physicians. Fam. Pract. 28 (6): 615-623. 10.1093/fampra/cmr040. 21746696.
18. Castle D. 2006. The balance between expertise and authority in citizen engagement about new biotechnology. Techné, 9 (3). 10.5840/techne2006931.
19. Castle D. Culver K. 2006. Public engagement, public consultation, innovation and the market. Integr. Assess. J. 6 (2): 137-152.
20. Castle D. Finlay K. 2006. Consumers' response to transgenic pork: the role of information. Asia-Pacific Advances in Consumer Research, 7: 283-284.
21. Castle D. Finlay K. Clark S. 2005. Proactive consumer consultation: the effect of information provision on response to transgenic animals. Journal of Public Affairs, 5 (3-4): 200-216. 10.1002/pa.22.
22. Catanzariti L. Faulks K. Moon L. Waters A.-M. Flack J. Craig M.E. 2009. Australia's national trends in the incidence of Type 1 diabetes in 0-14-year-olds, 2000-2006. Diabet Med. 26 (6): 596-601. 10.1111/j.1464-5491. 2009.02737.x. 19538234.
23. Caulfield T. Chandrasekharan S. Joly Y. Cook-Deegan R. 2013. Harm, hype and evidence: ELSI research and policy guidance. Genome Med. 5 (3): 21. 10.1186/gm425. 23534337.
24. Center M.M. Jemal A. Ward E. 2009. International trends in colorectal cancer incidence rates. Cancer Epidemiol. Biomarkers Prev. 18 (6): 1688-1694. 10.1158/1055-9965.EPI-09-0090. 19505900.
25. Corbin, J.M., and Strauss, A.L. 2008. Basics of qualitative research. 3rd ed. Sage Publications, Thousand Oaks, USA.
26. de Jong A.E. Hendriks Y.M. Kleibeuker J.H. de Boer S.Y. Cats A. Griffioen G. et al 2006. Decrease in mortality in Lynch syndrome families because of surveillance. Gastroenterology, 130 (3): 665-671. 10.1053/j.gastro.2005.11.032. 16530507. (Pubitemid 43374516)
27. Devendra D. Liu E. Eisenbarth G. 2004. Type 1 diabetes: recent developments. Br. Med. J. 328: 750-754. 10.1136/bmj.328.7442.750. (Pubitemid 38406430)
28. Di Angelantonio E. Butterworth A.S. 2012. Clinical utility of genetic variants for cardiovascular risk prediction: a futile exercise or insufficient data? Circ. Cardiovasc. Genet. 5 (4): 387-390. 10.1161/CIRCGENETICS.112.964148. 22896012.
29. Dunlop, M.G., Tenesa, A., Farrington, S.M., Ballereau, S., Brewster, D.H., Koessler, T., et al. 2012. Cumulative impact of common genetic variants and other risk factors on colorectal cancer risk in 42 103 individuals. Gut, 62: 871-881. 10.1136/gutjnl-2011-300537. 22490517.
30. Eisenberg M.E. Swain C. Bearinger L.H. Sieving R.E. Resnick M.D. 2005. Parental notification laws for minors' access to contraception. What do parents say? Arch. Pediatr. Adolesc. Med. 159: 120-125. 10.1001/archpedi.159.2.120. 15699304. (Pubitemid 40194176)
31. Fielding, N.G., and Lee, R.L. 1998. Computer analysis and qualitative research. Sage Publications, London, UK.
32. Green R.C. Green J.S. Buehler S.K. Robb J.D. Daftary D. Gallinger S. et al 2007. Very high incidence of familial colorectal cancer in Newfoundland: a comparison with Ontario and 13 other population-based studies. Fam. Cancer, 6 (1): 53-62. 10.1007/s10689-006-9104-x. (Pubitemid 46295298)
33. Grob R. 2008. Is my sick child healthy? Is my healthy child sick?: Changing parental experiences of cystic fibrosis in the age of expanded newborn screening. Soc. Sci. Med. 67: 1056-1064. 10.1016/j.socscimed.2008.06.003. 18639968.
34. Haddow, J.E., and Palomaki, G.E. 2003. ACCE: a model process for evaluating data on emerging genetic tests. In Human genome epidemiology: a scientific foundation for using genetic information to improve health and disease. Edited by M.J. Khoury, J. Little, and W. Burke. Oxford University Press, New York. pp. 217-233.
35. Haga S.B. Carrig M.M. O'Daniel J.M. Orlando L.A. Killeya-Jones L.A. Ginsburg G.S. et al 2011. Genomic risk profiling: attitudes and use in personal and clinical care of primary care physicians who offer risk profiling. J. Gen. Intern. Med. 26 (8): 834-840. 10.1007/s11606-011-1651-7. 21311998.
36. Hagopian W.A. Lernmark A. Rewers M.J. Simell O.G. She J.X. Ziegler A.G. et al 2006. TEDDY-The Environmental Determinants of Diabetes in the Young: an observational clinical trial. Ann. N.Y. Acad. Sci. 1079: 320-326. 10.1196/annals.1375.049. 17130573. (Pubitemid 44968741)
37. Hawken S.J. Greenwood C.M. Hudson T.J. Kustra R. McLaughlin J. Yang Q. et al 2010. The utility and predictive value of combinations of low penetrance genes for screening and risk prediction of colorectal cancer. Hum. Genet. 128 (1): 89-101. 10.1007/s00439-010-0828-1. 20437058.
38. Hiraki S. Ormond K.E. Kim K. Ross L.F. 2006. Attitudes of genetic counselors towards expanding newborn screening and offering predictive genetic testing to children. Am. J. Med. Genet. 140 (21): 2312-2319. 10.1002/ajmg.a.31485. 17036312. (Pubitemid 44684957)
39. International Agency for Research on Cancer. 2008. Colorectal Cancer Incidence and Mortality Worldwide in 2008. [Online.] Available from: http://globocan.iarc.fr/factsheets/cancers/colorectal.asp [accessed 9 April 2013].
40. Keogh L.A. van Vliet C.M. Studdert D.M. Maskiell J.A. Macrae F.A. St John D.J. et al 2009. Is uptake of genetic testing for colorectal cancer influenced by knowledge of insurance implications? Med. J. Aust. 191: 255-258. 19740045.
41. Kerruish N.J. 2011. Parents' experiences of newborn screening for genetic susceptibility to type 1 diabetes. J. Med. Ethics, 37 (6): 348-353. 10.1136/jme.2010.039206.
42. Kerruish N.J. Campbell-Stokes P.L. Gray A. Merriman T.R. Robertson S.P. Taylor B.J. 2007. Maternal psychological reaction to newborn genetic screening for type 1 diabetes. Pediatrics, 120 (2): e324-e335. 10.1542/peds.2006-1381. 17609310.
43. Khoury M.J. 2010. Dealing with the evidence dilemma in genomics and personalized medicine. Clin. Pharmacol. Ther. 87 (6): 635-638. 10.1038/clpt.2010.4. 20485318.
44. Khoury M.J. Yang Q. Gwinn M. Little J. Flanders D.W. 2004. An epidemiologic assessment of genomic profiling for measuring susceptibility to common diseases and targeting interventions. Genet. Med. 6 (1): 38-47. 10.1097/01.GIM.0000105751.71430.79. 14726808. (Pubitemid 38175976)
45. Lehoux P. Blume S. 2000. Technology assessment and the sociopolitics of health technologies. Journal of Health Politics, Policy and Law, 25 (6): 1083-1120. 10.1215/03616878-25-6-1083.
46. Mesters I. Ausems A. de Vries H. 2005. General public's knowledge, interest and information needs related to genetic cancer: an exploratory study. Eur. J. Cancer Prev. 14: 69-75. 10.1097/00008469-200502000-00010. 15677898. (Pubitemid 40396933)
47. Michailidou K. Hall P. Gonzalez-Neira A. Ghoussaini M. Dennis J. Milne R.L. et al 2013. Large-scale genotyping identifies 41 new loci associated with breast cancer risk. Nat. Genet. 45 (4): 353-361. 10.1038/ng.2563. 23535729.
48. Miller F.A. Carroll J.C. Wilson B.J. Bytautas J.P. Allanson J. Cappelli M. et al 2010. The primary care physician role in cancer genetics: a qualitative study of patient experience. Fam. Pract. 27 (5): 563-569. 10.1093/fampra/ cmq035. 20534792.
49. Morse J.M. Barrett M. Mayan M. Olsen K. Spiers J. 2002. Verification strategies for establishing reliability and validity in qualitative research. Int. J. Qual. Methods, 1 (2): 13-22.
50. Murphy E. Dingwall R. Greatbatch D. Parker S. Watson P. 1998. Qualitative research methods in health technology assessment: a review of the literature. Health Technol. Assess. 2: 1-274. 9919458.
51. Potter B.K. Avard D. Entwistle V. Kennedy C. Chakraborty P. McGuire M. et al 2009. Ethical, legal, and social issues in health technology assessment for prenatal/preconceptional and newborn screening: a workshop report. Public Health Genomics, 12 (1): 4-10. 10.1159/000153430. 19023190.
52. Ramsey S.D. Wilson S. Spencer A. Geidzinska A. Newcomb P. 2003. Attitudes towards genetic screening for predisposition to colon cancer among cancer patients, their relatives and members of the community. Results of focus group interviews. Community Genet. 6 (1): 29-36. 10.1159/000069543. (Pubitemid 36693836)
53. Rose A. Peters N. Shea J.A. Armstrong K. 2005. The association between knowledge and attitudes about genetic testing for cancer risk in the United States. J. Health Commun. 10 (4): 309-321. 10.1080/10810730590950039. 16036738. (Pubitemid 40980947)
54. Ross L.F. 2001. Genetic exceptionalism vs. paradigm shift: lessons from HIV. J. Law Med. Ethics, 29: 141-148. 10.1111/j.1748-720X. 2001.tb00701.x. (Pubitemid 33723263)
55. Ross L.F. 2003. Minimizing risks. The ethics of predictive diabetes mellitus screening research in newborns. Arch. Pediatr. Adolesc. Med. 157: 89-95.
56. Ross L.F. 2007. Against newborn screening for type 1 diabetes. Arch. Pediatr. Adolesc. Med. 161: 616-617. 10.1001/archpedi.161.6.616-c. 17548771. (Pubitemid 46878694)
57. Saukko P.M. Richards S.H. Shepherd M.H. Campbell J.L. 2006. Are genetic tests exceptional? Lessons from a qualitative study on thrombophilia. Soc. Sci. Med. 63 (7): 1947-1959. 10.1016/j.socscimed.2006.04.012.
58. Scientific Software Development. 2007. ATLAS/ti. Version 5.2. 5.2 ed. Berlin.
59. Secretary's Advisory Committee on Genetic Testing. 2000. Enhancing the oversight of genetic tests: recommendations of the SACGT. National Institutes of Health, Bethesda, Maryland.
60. Strauss, A.L. 1996. Qualitative analysis for social scientists. Cambridge University Press, Cambridge, UK.
61. Tenesa A. Dunlop M.G. 2009. New insights into the aetiology of colorectal cancer from genome-wide association studies. Nat. Rev. Genet. 10: 353-358. 10.1038/nrg2574. 19434079.
62. Teutsch S.M. Bradley L.A. Palomaki G.E. Haddow J.E. Piper M. Calonge N. et al 2009. The Evaluation of Genomic Applications in Practice and Prevention (EGAPP) Initiative: methods of the EGAPP Working Group. Genet. Med. 11 (1): 3-14. 10.1097/GIM.0b013e318184137c. 18813139.
63. Varga C. Brookes H. 2008. Factors influencing teen mothers' enrollment and participation in prevention of mother-to-child HIV transmission services in Limpopo Province, South Africa. Qual. Health Res. 18 (6): 786-802. 10.1177/1049732308318449. 18503020. (Pubitemid 351715939)
64. von Wagner C. Good A. Smith S.G. Wardle J. 2012. Responses to procedural information about colorectal cancer screening using faecal occult blood testing: the role of consideration of future consequences. Health Expect. 15 (2): 176-186. 10.1111/j.1369-7625.2011.00675.x. 21501350.
65. Vries H. Mesters I. van de Steeg H. Honing C. 2005. The general public's information needs and perceptions regarding hereditary cancer: an application of the Integrated Change Model. Patient Educ. Couns. 56 (2): 154-165. 10.1016/j.pec.2004.01.002. 15653244. (Pubitemid 40093813)
66. Wakefield C.E. Kasparian N.A. Meiser B. Homewood J. Kirk J. Tucker K. 2007. Attitudes toward genetic testing for cancer risk after genetic counseling and decision support: a qualitative comparison between hereditary cancer types. Genet. Test. 11 (4): 401-411. 10.1089/gte.2007.0013. 18294057.
67. Walsh J.M.E. Terdiman J.P. 2003. Colorectal cancer. Scientific review. J. Am Med. Assoc. 289: 1288-1296. 10.1001/jama.289.10.1288.
68. Walsh J. Arora M. Hosenfeld C. Ladabaum U. Kuppermann M. Knight S.J. 2012. Preferences for genetic testing to identify hereditary colorectal cancer: perspectives of high-risk patients, community members, and clinicians. J. Cancer Educ. 27 (1): 112-119. 10.1007/s13187-011-0286-z. 22131063.
69. Wilson, J.M.G., and Jungner, G. 1968. Principles and practice of screening for disease. WHO, Geneva, Switzerland.
70. Woods M.O. Hyde A.J. Curtis F.K. Stuckless S. Green J.S. Pollett A.F. et al 2005. High frequency of hereditary colorectal cancer in Newfoundland likely involves novel susceptibility genes. Clin. Cancer Res. 11 (19 Pt 1): 6853-6861. 10.1158/1078-0432.CCR-05-0726. (Pubitemid 41428740)
71. Yang Q. Khoury M.J. Botto L. Friedman J.M. Flanders W.D. 2003. Improving the prediction of complex diseases by testing for multiple disease- susceptibility genes. Am. J. Hum. Genet. 72 (3): 636-649. 10.1086/367923. 12592605. (Pubitemid 36255962)